Cases selected for the AskAnzal weekly PMCPA insight newsletter
Complaint about Trajenta online banner claims (βbroad rangeβ, βunique convenienceβ) and legibility of prescribing info link. Panel found…
Complaint about Sanofiβs flu vaccine ordering communications and a 30% QIVe dose reduction (with QIVr as an alternative).…
A corporate LinkedIn post named brands and an indication for a newly authorised SLIT tablet. PMCPA ruled this…
Kesimpta promo webpage implied unrestricted SMC approval (restriction not in immediate view). A UK HCP banner ad omitted…
Anonymous complaint alleged a Phase 2/3 sarcoma trial flyer in conference bags was pre-licence promotion and inappropriately distributed.…
Anonymous ex-employee alleged Moderna misused preprint vaccine effectiveness data, cherry-picked graphs and sought UK contract advantage via JCVI…
A medical publisherβs βSponsoredβ Facebook ad linked to a Lilly-funded breast cancer article. The Panel found disguised promotion,…
A pharmacist challenged claims that Versatis was comparable to pregabalin (and possibly gabapentin) and had fewer side-effects/interactions. The…
GSK and Roche withdrew Bonviva βBuilding Bonesβ materials after an undertaking, but Pulse republished the old ad. Panel…
Actiq ad and leavepiece implied breakthrough cancer pain control could be switched βonβ and βoffβ like an appliance.…
One real case. One key lesson. Every week β free.